Procept Biorobotics
PRCT
117 hedge funds and large institutions have $1.36B invested in Procept Biorobotics in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 30 reducing their positions, and 10 closing their positions.
150% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 10
57% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 30
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
14% more funds holding
Funds holding: 103 → 117 (+14)
3% less capital invested
Capital invested by funds: $1.4B → $1.36B (-$35.6M)
2.29% less ownership
Funds ownership: 75.52% → 73.23% (-2.3%)
92% less call options, than puts
Call options by funds: $656K | Put options by funds: $7.86M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$25M |
| 2 |
YU
Yale University
New Haven,
Connecticut
|
+$24M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17M |
| 5 |
Millennium Management
New York
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
CPMG Inc
Dallas,
Texas
|
-$160M |
| 2 |
JJ
Johnson & Johnson
New Brunswick,
New Jersey
|
-$21.7M |
| 3 |
PA
Perceptive Advisors
New York
|
-$8.55M |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$4.03M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.42M |
PRCT Hedge Fund Activity: Q4 2022 in Review
117 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q4 2022, worth a combined $1.36B — down 2.6% from $1.4B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new PRCT positions and 10 closed out — a net gain of 15 holders — while 47 added to existing stakes and 30 trimmed.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $25M. The largest seller was CPMG Inc, cutting an estimated $160M.
- 117 institutional investors held Procept Biorobotics (PRCT) as of Q4 2022, up from 103 in Q3 2022.
- Funds reported $1.36B of Procept Biorobotics stock for Q4 2022, down 2.6% quarter-over-quarter.
- 25 funds opened new Procept Biorobotics positions in Q4 2022 and 10 closed out, a net change of +15 holders.
- The largest Procept Biorobotics buyer in Q4 2022 was Loomis, Sayles & Company, an estimated $25M added.
- The largest Procept Biorobotics seller in Q4 2022 was CPMG Inc, an estimated $160M sold.
Based on aggregated 13F filings for Q4 2022.